Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act
Prihatha R. Narasimmaraj, Andrew S. Oseran, Archana Tale, Jiaman Xu, Utibe R. Essien, Dhruv S. Kazi, Robert W. Yeh, Rishi K. Wadhera
Topics & Concepts
MedicinePrescription drugMedical prescriptionMedicare Part DPopulationEnvironmental healthDrugDemographyPharmacologySociologyMedication Adherence and ComplianceEconomic and Financial Impacts of CancerPharmaceutical Economics and Policy